Citation Impact
Citing Papers
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Fibrotic Focus in Invasive Ductal Carcinoma of the Breast: A Histopathological Prognostic Parameter for Tumor Recurrence and Tumor Death within Three Years after the Initial Operation
1997
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Fcγ receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity
2006
Prognostic Factors in Breast Cancer
2000
Two-Color, Cytokeratin-Labeled DNA Flow Cytometric Analysis of 332 Breast Cancers
2001
Clinicopathologic Study and DNA Analysis of 37 Cardiac Myxomas
2003
Immunophenotyping of cytologic specimens by flow cytometry
1993
Ulcerative Colitis
2011 Standout
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
1997 StandoutNobel
Drug penetration in solid tumours
2006 Standout
Rituximab
2003
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
2001 StandoutNature
S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer
1998
Highly multiplexed simultaneous detection of RNAs and proteins in single cells
2016
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Optimal number of reagents required to evaluate hematolymphoid neoplasias: Results of an international consensus meeting
2001
The molecular biology of head and neck cancer
2010 Standout
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC
2006
Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045
1998
Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial
2000
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens
1996
Analysis of renal fibrosis in a rabbit model of crescentic nephritis.
1988
Oesophageal carcinoma
2013 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Monoclonal antibodies as therapeutic agents for cancer
2004
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
1997 Standout
Simultaneous epitope and transcriptome measurement in single cells
2017 Standout
Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study
2009
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
2004 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer
2004
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Regulation of type I interferon responses
2013 Standout
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables
2001
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Standardizing immunophenotyping for the Human Immunology Project
2012
American Joint Committee on Cancer prognostic factors consensus conference
2000
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization
2001
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
1998
Prognostic value of S‐phase cells in AML patients
1995
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000
S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
2001
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans
2002 Standout
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
1991 Standout
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
2004 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Cell Surface Antigen and Molecular Targeting in the Treatment of Hematologic Malignancies
2002
Influence of Sulfation on Platelet Aggregation and Activation with Differentially Sulfated Hyaluronic Acids
1998
Shock and Tissue Injury Induced by Recombinant Human Cachectin
1986 StandoutScienceNobel
Possible Mechanisms of Bleomycin-Induced Fibrosis
1990
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
1999
Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity
2000
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Human polymorphonuclear neutrophil activation with arachidonic acid
1987
Characterization and Mutagenesis of Gal/GlcNAc-6-O-sulfotransferases
2002 StandoutNobel
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
1994
Guidelines for the Primary Prevention of Stroke
2014 Standout
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
A new staging system for multiple myeloma based on the number of S- phase plasma cells
1995
Carbohydrate Sulfotransferases of the GalNAc/Gal/GlcNAc6ST Family
2002 StandoutNobel
Potent Immunoregulatory Effects ofSalmonella typhiFlagella on Antigenic Stimulation of Human Peripheral Blood Mononuclear Cells
1999
Huge Fetal Sacrococcygeal Teratoma with a Completely Formed Eye and Intratumoral DNA Ploidy Heterogeneity
1999
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
A new staging system for multiple myeloma based on the number of S- phase plasma cells
1995
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.
1986
Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture
2001
Interactions of granulocytes with the lungs.
1984
Pleural Effusion
2002 Standout
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Genomic Biomarkers to Improve Ulcerative Colitis Neoplasia Surveillance
2008
Secretory products of macrophages.
1987 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils
1990 StandoutNobel
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999
International Staging System for Multiple Myeloma
2005 Standout
Works of Ricardo E. Duque being referenced
Clinical flow cytometry : principles and application
1993
Flow Cytometric Analysis of Lymphomas and Acute Leukemias
1993
Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia
1992
U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations
1997
High-grade B-cell lymphoma presenting as polyserosal disease. Diagnosis by flow cytometry
1989
Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology
1993
Guidelines for implementation of clinical DNA cytometry
1993
Effect of the Beige Mutation on Bleomycin-induced Pulmonary Fibrosis in Mice 1, 2
1983
Inhibition of neutrophil activation by p‐bromophenacyl bromide and its effects on phospholipase A2
1986
Guidelines for the implementation of clinical DNA cytometry
1993
Flow cytometric analysis of acute leukemias
1990
The macrophage adherence phenomenon: Its relationship to prostaglandin E2 and superoxide anion production and changes in transmembrane potential
1983